G Ramadori

Peginterferon alfa-2A (40 KD) (PEGASYS) in combination with ribavirin (RBV): efficacy and safety results from a phase III, randomized, double-blind, multicentre study examining effect of duration of treatment and RBV dose

S. Hadziyannis, Hugo Cheinquer, Timothy M. Morgan et al. · Journal of Hepatology · 2002 · 133 citations

Medicine, Phase Iii, Clinical Trials +9

Biosynthesis of Lipopolysaccharide-Binding Protein in Rabbit Hepatocytes

G Ramadori, Meyer zum Büschenfelde, Peter S. Tobias et al. · Pathobiology · 1990 · 91 citations

Biosynthesis, Protein Expression, Hepatology +15

A NOVEL MANAGEMENT STRATEGY OF STEROID-FREE IMMUNOSUPPRESSION AFTER LIVER TRANSPLANTATION: EFFICACY AND SAFETY OF TACROLIMUS AND MYCOPHENOLATE MOFETIL

B. Ringe, Felix Braun, Ekkehard Sch tz et al. · Transplantation · 2001 · 84 citations

Twelve versus 36 months of adjuvant imatinib (IM) as treatment of operable GIST with a high risk of recurrence: Final results of a randomized trial (SSGXVIII/AIO).

Heikki Joensuu, Mikael Eriksson, J. Hatrmann et al. · Journal of Clinical Oncology · 2011 · 79 citations

Surgical Oncology, Cancer Management, Immunology +16

Clonal analysis of human T lymphocytes infiltrating the liver in chronic active hepatitis B and primary biliary cirrhosis

Stefan Meuer, Ulrich Moebius, Michael Manns et al. · European Journal of Immunology · 1988 · 64 citations